185 related articles for article (PubMed ID: 18537677)
1. Extracellular SH3 domain containing proteins--features of a new protein family.
Stoll R; Bosserhoff A
Curr Protein Pept Sci; 2008 Jun; 9(3):221-6. PubMed ID: 18537677
[TBL] [Abstract][Full Text] [Related]
2. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.
Stoll R; Renner C; Zweckstetter M; Brüggert M; Ambrosius D; Palme S; Engh RA; Golob M; Breibach I; Buettner R; Voelter W; Holak TA; Bosserhoff AK
EMBO J; 2001 Feb; 20(3):340-9. PubMed ID: 11157741
[TBL] [Abstract][Full Text] [Related]
3. NMR-based Drug Development and Improvement Against Malignant Melanoma - Implications for the MIA Protein Family.
Arnolds O; Zhong X; Tuo Yip K; Schöpel M; Kohl B; Pütz S; Abdel-Jalil R; Stoll R
Curr Med Chem; 2017; 24(17):1788-1796. PubMed ID: 28595551
[TBL] [Abstract][Full Text] [Related]
4. Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains.
Stoll R; Renner C; Buettner R; Voelter W; Bosserhoff AK; Holak TA
Protein Sci; 2003 Mar; 12(3):510-9. PubMed ID: 12592021
[TBL] [Abstract][Full Text] [Related]
5. Expression, function and clinical relevance of MIA (melanoma inhibitory activity).
Bosserhoff AK; Buettner R
Histol Histopathol; 2002 Jan; 17(1):289-300. PubMed ID: 11813878
[TBL] [Abstract][Full Text] [Related]
6. Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.
Lougheed JC; Holton JM; Alber T; Bazan JF; Handel TM
Proc Natl Acad Sci U S A; 2001 May; 98(10):5515-20. PubMed ID: 11331761
[TBL] [Abstract][Full Text] [Related]
7. Solution structure and dynamics of melanoma inhibitory activity protein.
Lougheed JC; Domaille PJ; Handel TM
J Biomol NMR; 2002 Mar; 22(3):211-23. PubMed ID: 11991352
[TBL] [Abstract][Full Text] [Related]
8. Solution structure and peptide binding of the SH3 domain from human Fyn.
Morton CJ; Pugh DJ; Brown EL; Kahmann JD; Renzoni DA; Campbell ID
Structure; 1996 Jun; 4(6):705-14. PubMed ID: 8805554
[TBL] [Abstract][Full Text] [Related]
9. Characterization and expression pattern of the novel MIA homolog TANGO.
Bosserhoff AK; Moser M; Buettner R
Gene Expr Patterns; 2004 Jul; 4(4):473-9. PubMed ID: 15183315
[TBL] [Abstract][Full Text] [Related]
10. Detailed analysis of MIA protein by mutagenesis.
Stoll R; Lodermeyer S; Bosserhoff AK
Biol Chem; 2006 Dec; 387(12):1601-6. PubMed ID: 17132106
[TBL] [Abstract][Full Text] [Related]
11. Solution NMR structure and ligand identification of human Gas7 SH3 domain reveal a typical SH3 fold but a non-canonical ligand-binding mode.
Nie Y; Zhu J; Ramelot TA; Kennedy MA; Liu M; He T; Yang Y
Biochem Biophys Res Commun; 2019 Sep; 516(4):1190-1195. PubMed ID: 31296381
[TBL] [Abstract][Full Text] [Related]
12. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
[TBL] [Abstract][Full Text] [Related]
14. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
[TBL] [Abstract][Full Text] [Related]
15. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
16. Identification of two distinct peptide-binding pockets in the SH3 domain of human mixed-lineage kinase 3.
Kokoszka ME; Kall SL; Khosla S; McGinnis JE; Lavie A; Kay BK
J Biol Chem; 2018 Aug; 293(35):13553-13565. PubMed ID: 29980598
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
18. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
[TBL] [Abstract][Full Text] [Related]
19. Phage display selection of ligand residues important for Src homology 3 domain binding specificity.
Rickles RJ; Botfield MC; Zhou XM; Henry PA; Brugge JS; Zoller MJ
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10909-13. PubMed ID: 7479908
[TBL] [Abstract][Full Text] [Related]
20. Folding Mechanism of the SH3 Domain from Grb2.
Troilo F; Bonetti D; Camilloni C; Toto A; Longhi S; Brunori M; Gianni S
J Phys Chem B; 2018 Dec; 122(49):11166-11173. PubMed ID: 30091591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]